Protea Offers Compelling Value Proposition to Investors
REDONDO BEACH, CA / ACCESSWIRE / September 24, 2015 / The best biotech opportunities disrupt large and established markets with new technologies capable of improving efficacy and/or lowering cost. For...
View ArticlePharmaCyte Biotech Discusses Pancreatic Cancer Treatment for Upcoming Phase...
(Source: PharmaCyte Biotech Inc) SILVER SPRING, Md., Sept. 22, 2015 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments...
View ArticleNeopeutics Takes Home the Frost & Sullivan 2015 Technology Leadership Award...
MOUNTAIN VIEW, Calif., Sept. 23, 2015 /PRNewswire/ -- Frost & Sullivan honored Neopeutics, Inc. with the 2015 North America Frost & Sullivan Award for Technology Leadership at its glittering...
View ArticleGenomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in...
Abstract Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. Recent high-throughput analyses of genomic alterations revealed several driver genes and altered pathways in...
View ArticleVerastem Announces New Research Published in the Journal Cell That Highlights...
(Source: Verastem Inc) BOSTON--(BUSINESS WIRE)--Sep. 24, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells,...
View ArticleTeam to explore using nanoparticles to fight cancer September 24, 2015...
(Source: Vanderbilt University) Team to explore using nanoparticles to fight cancer by Dagny Stuart | Thursday, Sep. 24, 2015, 10:33 AM Craig Duvall, Ph.D., left, Julie Sterling, Ph.D., and Scott...
View ArticleSharing Pancreatic Cancer Treatment Information -- A Lifeline
There are some people who come into your life and feel like a gift. That's how I feel about Dr. Mark Ricigliano, a brilliant scientist and relentless champion for better pancreatic cancer treatments....
View ArticleDrug Self-Administration to 2022
LONDON, Sept. 23, 2015 /PRNewswire/ -- While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot...
View ArticlePen Injectors to 2022
LONDON, Sept. 23, 2015 /PRNewswire/ -- User-friendly designs and the availability of an increasing number of drugs in pre-filled disposable cartridges and syringes are propelling the growth of injector...
View ArticleGlobal Molecular Diagnostics Deal Trends, Players, Financials and Forecasts...
DUBLIN, Sept. 23, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8hkj93/global_molecular) has announced the addition of the "Global Molecular Diagnostics...
View ArticleGlobal Mobile Analytics Market - Trends and Forecasts (2015-2020)
LONDON, Sept. 23, 2015 /PRNewswire/ -- Mobile Analytics is the branch of analytics specific to a particular mobile platform to improve business performance, make timely and informed decisions for...
View ArticleAutoinjectors to 2022
LONDON, Sept. 23, 2015 /PRNewswire/ -- Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and...
View ArticleResearchers develop strategy for determining how non-coding gene sequences...
(Source: Massachusetts General Hospital) A paper receiving advance online release in Nature Medicine describes a strategy for meeting one of today's most significant challenges in genomic medicine -...
View ArticleAtara Bio's T-Cell Product Candidate Activated Against Wilms' Tumor 1 Protein...
(Source: Atara Biotherapeutics Inc) SOUTH SAN FRANCISCO, Calif., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), today announced that its collaborating investigators at...
View ArticleBIND Therapeutics Announces Pfizer Inc. Exercises Option to Advance...
(Source: BIND Therapeutics Inc) -- BIND earns $2.5 million option fee for first compound in global collaboration to pursue development and commercialization of novel Accurins -- CAMBRIDGE,...
View ArticleCelator® Pharmaceuticals Announces Positive Results from R&D Programs -...
EWING, N.J., Sept. 24, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to...
View ArticlePRESCRIPTION PAIN DRUGS-INCLUDING OPIOID, ANTICONVULSANT, INJECTABLE/INHALED,...
LONDON, Sept. 24, 2015 /PRNewswire/ -- Abstract Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. At some point, everyone experiences...
View ArticlePrefilled Syringes to 2022
LONDON, Sept. 23, 2015 /PRNewswire/ --The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this...
View ArticleClinical Data for Trovagene's Precision Cancer Monitoring Platform Presented...
SAN DIEGO, Sept. 24, 2015 /PRNewswire/ -- Trovagene, Inc., (NASDAQ: TROV) a developer of cell-free molecular diagnostics, announced today the presentation of clinical results featuring the use of its...
View ArticleClovis Oncology Announces Data Presentations at 2015 European Cancer Congress...
(Source: Clovis Oncology Inc) Clovis Oncology Announces Data Presentations at 2015 European Cancer Congress Three oral presentations and four scientific posters selected for presentation at the...
View Article
